Semi-Solid Dosage Form Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Semi-Solid Dosage Form Drugs Market Analysis

The Semi-solid Dosage Form Drugs Market size is estimated at USD 123.20 billion in 2024, and is expected to reach USD 162.5 billion by 2029, growing at a CAGR of 5.70% during the forecast period (2024-2029).

The key factor driving the growth of the market is the rising prevalence of skin-related diseases such as acne, dermatitis, and fungal infections and the site-specific action of semi-solid preparations in various dermatological conditions.

Fungal infections on the skin are common and frequently treated with semi-solid products such as creams, gels, lotions, solutions, or ointments. Various advances in semi-solid dosage forms, such as incorporating nanoparticles in antifungal ointments, have emerged as a new area for development among researchers. For instance, in an article published in January 2024 in the Discover Nano journal, the researchers showed that nanoparticle-based antifungal ointments showed a significant potential to treat fungal diseases. Incorporation of nanoparticles can hold multiple antifungal drugs as a combination therapy for different types of fungal infections. Thus, owing to such advantages offered by the semi-solid preparations, the demand is likely to rise, leading to market growth during the forecast period.

Also, the high burden of various dermatological conditions is expected to require various semi-solid preparations. For instance, as per the article published in February 2024 in the Scientific Reports journal, based on a questionnaire conducted among the medical students at An-Najah National University (ANU) in Palestine, the researchers found that the prevalence of acne among women was higher with 85% compared to the overall population. Thus, owing to the occurrence of acne issues, the demand for semi-solid products is likely to rise, leading to market growth during the forecast period.

Additionally, an increased number of psoriasis cases enhances the need for various skin ointments and gels to treat the condition. For instance, as per the August 2023 update by Skin Health Institute, psoriasis is anticipated to impact around 2-3% of the Australian population, ultimately leading to a common dermatological condition in the country. Thus, owing to the occurrence of such dermatological conditions, the demand for semi-solid products is likely to rise, promoting market growth during the forecast period.

Also, significant product launches and regulatory approvals related to ointments, creams, and other dermatological products are expected to boost the market growth during the forecast period. For instance, in April 2023, Zydus Lifesciences received approval from the US Food and Drug Administration to market metronidazole topical cream to treat a skin disorder known as rosacea. Hence, such regulatory approvals are expected to drive market growth during the forecast period. Thus, due to the increase in dermatological and skin diseases, the rise in benefits offered by the semi-solid preparation in treating various skin conditions, and notable regulatory approvals for semi-solid products, the market is expected to witness a notable growth during the forecast period. However, stringent regulatory scenarios and an increase in pricing pressure on pharmaceutical companies are expected to restrain the market growth.

Semi-Solid Dosage Form Drugs Market Trends

The Ointments Segment is Anticipated to Witness a Healthy Growth During the Forecast Period

Semi-Solid Dosage Form Drugs Industry Segmentation

The semi-solid dosage form drugs are either applied directly to the skin topically or administered via a suppository.

The semi-solid dosage form drugs market is segmented by product type, route of administration, end users, and geography. By product type, the market is segmented into ointments, pastes, creams, gels, and other product types. By route of administration, the market is segmented into skin, nasal cavity, and rectal cavity. By end user, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers market size and forecasts for the semi-solid dosage form drugs market in value (USD) for the above segments.